Mark Hoogendijk

Dr. Mark Hoogendijk is a Researcher in the Department of Cardiology at Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, specializing in cardiac electrophysiology with a focus on atrial fibrillation mechanisms and ablation therapies.

His primary research interests include:

• Atrial Fibrillation
• Heart Ventricle Arrhythmia
• Pulmonary Vein Isolation
• Recurrent Disease
• Persistent Atrial Fibrillation
• ST Elevation
• Brugada Syndrome
• Radiofrequency Ablation

Recent publications (2024-2025) demonstrate a concentrated effort to optimize ablation techniques through engineering innovations and clinical validation. Key trends include development of hexagonal multielectrode systems for superior electrogram recording, size-adjustable cryoballoons for precise pulmonary vein isolation, and high-power short-duration radiofrequency protocols that rival cryoablation efficacy. His work with the AF-FLOW Global Registry establishes electrographic flow mapping as a critical phenotyping tool, while device infection risk stratification research addresses post-implant complications.

No documented scientific awards are currently associated with his profile.

Dr. Hoogendijk actively collaborates in international research networks including the AF-FLOW Global Registry consortium. His 36 research outputs reveal extensive co-authorship with Erasmus MC colleagues across cardiology, electrophysiology, and biomedical engineering disciplines, though specific grant funding details remain unreported. Current work centers on translational projects bridging cardiac mapping technology with clinical ablation workflows.